GO
Loading...

Medtronic Inc

More

  • Final Glance: Medical Devices companies Monday, 7 Apr 2014 | 6:01 PM ET

    Allergan fell $3.35 or 2.7 percent, to $120.77. Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Boston Scientific Corp. fell$. 28 or 2.1 percent, to $13.22.

  • Midday Glance: Medical Devices companies Monday, 7 Apr 2014 | 1:50 PM ET

    Allergan fell $3.31 or 2.7 percent, to $120.81. Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $13.35.

  • Final Glance: Medical Devices companies Friday, 4 Apr 2014 | 6:19 PM ET

    Allergan fell $1.26 or 1.0 percent, to $124.12. Baxter International Inc. fell$. 46 or. 6 percent, to $72.93. Boston Scientific Corp. fell$. 27 or 2.0 percent, to $13.50.

  • Midday Glance: Medical Devices companies Friday, 4 Apr 2014 | 1:20 PM ET

    Allergan fell$. 24 or. 2 percent, to $125.14. Baxter International Inc. rose$. 26 or. 3 percent, to $73.64. Boston Scientific Corp. fell$. 21 or 1.5 percent, to $13.57.

  • Early Glance: Medical Devices companies Friday, 4 Apr 2014 | 10:57 AM ET

    Allergan rose$. 66 or. 5 percent, to $126.04. Baxter International Inc. rose$. 24 or. 3 percent, to $73.63. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.85.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

  • Just ask Bob Costas, who arrived in Sochi to be the main host of NBC's prime time Olympic coverage, and ended up on the sidelines for nearly a week with an eye infection. Heather Holmes, who works for the medical device company Medtronic Inc, regularly puts in more than 100,000 miles a year on long flights to such places as China and India.

  • FRANKFURT, Feb 27- Bayer said it would buy privately held Dihon Pharmaceutical Group Co, a maker of traditional herbal Chinese medicines, as the German drugmaker pushes to become the world's largest non-prescription medicines group.

  • Feb 18- Medtronic Inc on Tuesday reported a lower quarterly net profit after it took charges for an experimental blood pressure device that failed to prove effective in a clinical study. Medtronic shares fell 2.3 percent to $55.56 in morning trading on the New York Stock Exchange.

  • Feb 18- Medtronic Inc on Tuesday reported lower quarterly net earnings due to charges for the failed clinical study of a treatment being developed for high blood pressure. Excluding the charges and other one-time items, Medtronic earned 91 cents a share, in line with the analysts' average estimate, according to Thomson Reuters I/B/E/S.

  • Early movers: KO, FRX, WM, MDT, NFLX, TSLA & more Tuesday, 18 Feb 2014 | 8:08 AM ET

    Some of the names on the move ahead of the open.

  • Medtronic posts lower earnings on charges Tuesday, 18 Feb 2014 | 7:34 AM ET

    Feb 18- Medtronic Inc on Tuesday reported lower quarterly net earnings due to charges for the failed clinical study of a treatment being developed for high blood pressure. The maker of pacemakers, spinal products, insulin pumps and other medical devices said net earnings were $762 million, or 75 cents a share, in the third quarter ended Jan. 24.

  • Squawking Sochi curling, vodka and Fashion Week Thursday, 13 Feb 2014 | 4:02 PM ET

    This is Talking Squawk, the official "Squawk Box" blog, providing tidbits, insights and sarcastic reflections.

  • Feb 4- Medtronic Inc's stumble in its U.S. medical device study to treat high blood pressure could create an opportunity for other device makers to pick up where their rival has left off, Boston Scientific Corp Chief Executive Mike Mahoney said on Tuesday.

  • Midday movers: Apple, Intel, Dollar Tree & More Wednesday, 22 Jan 2014 | 12:30 PM ET

    Wednesday's midday movers:

  • Jan 21- Jan 21- Covidien Plc said it would stop making a device for treating high blood pressure due to weak demand for the product, raising more doubts about the future of the novel technology.

  • Jan 17- Medtronic Inc's minimally invasive system for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

  • Midday movers: UPS, Best Buy, Twitter & More Friday, 17 Jan 2014 | 12:12 PM ET
    A UPS worker delivers packages in Chicago.

    Some of Friday's midday movers:

Most Popular Video

Wednesday, 16 Apr 2014 | 3:00 AM ET

European shares opened higher on Wednesday as better-than-expected Chinese growth data buoyed sentiment.

Wednesday, 16 Apr 2014 | 2:00 AM ET

Brady Dougan, CEO of Credit Suisse, says the bank's fixed income business is "strong", while the investment banking arm has performed well.

Tuesday, 15 Apr 2014 | 7:31 PM ET

Hiroshi Miyoshi, Mitsubishi CEO for Turkey and Central Asia, describes Turkey's appeal to Japanese firms, who invested $500 million in the emerging market last year.